Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Research

Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral drugs that may help stop or delay the decline of kidney function, or even improve it.

Mayo Clinic also heads the Nephrology Collaborative Group, a national consortium of doctors who specialize in kidney diseases (nephrologists). This group brings together clinicians and scientists to develop and conduct prospective studies aimed at treating people with kidney disease.

Research

See a list of publications on diabetic nephropathy by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

Research Profiles

Narrow Your Search

View All • All Locations

Diabetic nephropathy care at Mayo Clinic

Oct. 13, 2016
References
  1. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Feb. 11, 2016.
  2. Evert AB, et al. New diabetes nutrition therapy recommendations: What you need to know. Diabetes Spectrum. 2014;27:121.
  3. AskMayoExpert. Diabetic nephropathy. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2016.
  4. Goldman L, et al., eds. Diabetes and the kidney. In: Goldman-Cecil Medicine. 25th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. http://www.clinicalkey.com. Accessed June 10, 2016.
  5. Goldman L, et al., eds. Approach to the patient with renal disease. In: Goldman-Cecil Medicine. 25th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. http://www.clinicalkey.com. Accessed June 10, 2016.
  6. Skorecki K, et al., eds. Diabetic nephropathy. In: Brenner and Rector's The Kidney. 10th ed. Philadelphia, Pa.: Elsevier; 2016. http://www.clinicalkey.com. Accessed June 10, 2016.
  7. Bakris GL, et al. Effect of finerenone on albuminuria in patients with diabetic nephropathy: A randomized clinical trial. JAMA. 2015;314:884.
  8. Diabetic nephropathy. Merck Manual Professional Version. https://www.merckmanuals.com/professional/genitourinary-disorders/glomerular-disorders/diabetic-nephropathy. Accessed June 10, 2016.
  9. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Diabetes and CKD: 2012 update. American Journal of Kidney Disease. 2012;60:850.
  10. Oshel K (expert opinion). Mayo Clinic, Jacksonville, Fla. Aug. 9, 2016.
  11. Johnson RJ, et al. Pathogenesis, clinical manifestations and natural history of diabetic nephropathy. In: Comprehensive Clinical Nephrology. 5th ed. Philadelphia, Pa.: Saunders Elsevier; 2015.
  12. Wein AJ, et al., eds. Etiology, pathogenesis and management of renal failure. In: Campbell-Walsh Urology. 11th ed. Philadelphia, Pa.: Elsevier; 2016. http://www.clinicalkey.com. Accessed June 10, 2016.
  13. Diabetes and chronic kidney disease. National Kidney Foundation. https://www.kidney.org/news/newsroom/factsheets/Diabetes-And-CKD. Accessed June 10, 2016.
  14. Preventing diabetic kidney disease: 10 answers to questions. National Kidney Foundation. https://www.kidney.org/atoz/content/preventkiddisease. Accessed June 10, 2016.
  15. Coping effectively: A guide for patients and their families. The National Kidney Foundation. https://www.kidney.org/atoz/content/coping_effectively_guide. Accessed June 10, 2016.
  16. Bakris GL. Overview of diabetic nephropathy. http://www.uptodate.com/home. Accessed June 10, 2016.
  17. Bakris GL. Treatment of diabetic nephropathy. http://www.uptodate.com/home. Accessed June 10, 2016.
  18. Sethi S, et al. Mayo Clinic/Renal Pathology Society consensus report on pathologic classification, diagnosis, and report of GN. Journal of the American Society of Nephrology. 2015;27:1.